Committee

JDRF Announces National Volunteer Award Recipients at Annual One Conference

Retrieved on: 
Wednesday, February 7, 2024
Jon Huntsman Jr., City, Partnership, Family, Olympic Games, Committee, Northern Tier (United States), Legislation, International Board, Volunteering, Mid-Atlantic, Carol, Policy, COVID-19, Paul's walk, Research, Uncertainty, Real estate, Innovation, Conference, Management

The volunteers were recognized with the awards at JDRF's annual One Conference on Feb. 6, 2024.

Key Points: 
  • The volunteers were recognized with the awards at JDRF's annual One Conference on Feb. 6, 2024.
  • Award recipients include:
    "For over 50 years, JDRF's progress has been fueled by strong, passionate volunteer leaders," said Aaron Kowalski, Ph.D., JDRF CEO.
  • The Jim Tyree Award recognizes a volunteer leader who has made a significant and noteworthy contribution to JDRF during their tenure of service.
  • Adam is a dynamic volunteer partner who consistently puts the needs of JDRF and the T1D community first.

Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update

Retrieved on: 
Wednesday, February 7, 2024
Clinical trial, Marketing authorisation, FDA, Expanded access, Genome, Frontotemporal dementia, Safety, Food, OLE, Real, CNS, Medicine, Publication, Committee, RTT, Rett syndrome, Patent, Marketing, CHMP, European, Human, DSM-IV codes, Research, Patient, Drug development, Pharmacokinetics, Pharmacology, Central nervous system, Webcast, Conference call, Doctor of Philosophy, Treatment, EDGAR, MECP2, Union, Therapy, EMA, RWE, Alzheimer's disease, European Medicines Agency, Neurodevelopmental disorder, Bank statement, Conference, Pharmaceutical industry

NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today reported financial results for its fiscal quarter ended December 31, 2023.

Key Points: 
  • The Marketing Authorisation would allow direct market access throughout the European Union for oral blarcamesine for the treatment of Alzheimer’s disease.
  • We intend to further assess the results and discuss with the regulatory authorities next steps.
  • General and administrative expenses for the quarter of $2.6 million compared to $3.3 million for the comparable first quarter of fiscal 2023.
  • Research and development expenses for the fourth quarter of $8.7 million compared to $12.1 million for the comparable first quarter of fiscal 2023.

Notice convening the Annual General Meeting of Valmet Oyj

Retrieved on: 
Wednesday, February 7, 2024
Language, Mass meeting, Exercise, Auditor, Section, EUR, Treasury, Webcast, Remuneration, Finance, Coffee, Annual, Chapter Five, Messukeskus Helsinki, KHT, Annual general meeting, Committee, Osakeyhtiö, Financial statement, Convention center, Policy, Report, Participation, Proxy, KRT, Investment, Audit committee, EET, Bank statement, Chapter Ten, Conference, Security (finance)

ESPOO, Finland, Feb. 7, 2024 /PRNewswire/ -- Notice is given to the shareholders of Valmet Oyj ("Valmet" or the "Company") to the Annual General Meeting to be held on March 21, 2024 starting at 1:00 p.m. (EET) at Siipi Conference Centre of Helsinki Expo and Convention Centre (Messukeskus Helsinki), hall 101 at the address Rautatieläisenkatu 3, 00520 Helsinki, Finland. The reception of the shareholders who have registered for the meeting and the distribution of voting tickets will commence at 12:00 noon.

Key Points: 
  • In addition, the shareholders who have registered for the meeting can follow the Annual General Meeting via a webcast.
  • For further instructions, please refer to Section C. "Instructions for the Participants in the Annual General Meeting" of this notice.
  • Valmet's Nomination Board proposes to the Annual General Meeting, that the number of members of the Board of Directors for the term expiring at the close of the Annual General Meeting 2025 be eight (8).
  • The Board of Directors proposes to the Annual General Meeting that the Annual General Meeting authorize the Board of Directors to resolve on the repurchase of the Company's own shares in one or several tranches.

The Eurosystem policy response to developments in retail payments

Retrieved on: 
Wednesday, February 7, 2024
Crypto, Multilateralism, Civil service commission, Section 2, International, Fraud, Ecosystem, Privacy, SIPS, Aggression, Architecture, Bank, ECB, OJ, Digital divide, Finance, Section 3, Internet, SPACE, Knowledge, Principle, Bank for International Settlements, Safety, FSB, PFMI, Council, Blog, TARGET, Artificial intelligence, CPSS, Central bank, Committee, ECRB, CPMI, IOSCO, Payment, International Organization (journal), Acceleration, Single Euro Payments Area, European Commission, Speech, Coronavirus, European Central Bank, Risk, Financial market, Face, Motivation, Euro, ICT, Policy, IBAN, Payments Council, European, Digital, Section 4, Fintech, European Payments Initiative, Digitalization, Perception, News, Instant, Sale, European Parliament, Conference, Online shopping

Retail payments are undergoing profound changes that are reshaping the European payments landscape.

Key Points: 
  • Retail payments are undergoing profound changes that are reshaping the European payments landscape.
  • The retail payments ecosystem and consumers’ attitudes and preferences are evolving and influencing one another.

Space Beach Law Lab Conference Convenes Space Law Leaders to Discuss Future of Space Law and Policy in Late February

Retrieved on: 
Tuesday, February 6, 2024
Other Travel, Legal, Aerospace, Travel, Manufacturing, Law Enforcement, Emergency Services, Other Transport, Public Policy, Government, Professional Services, Air, Defense, Transport, Other Defense, Other Policy Issues, Multimedia, Policy, Law, Glass, Lawyer, Female, Harbor, Committee, NASA

Growing interest in Space Law catalyzed the launch of the Space Beach Law Lab , an unprecedented conference taking place February 27-29, 2024 in Long Beach, California.

Key Points: 
  • Growing interest in Space Law catalyzed the launch of the Space Beach Law Lab , an unprecedented conference taking place February 27-29, 2024 in Long Beach, California.
  • The historic event will bring together luminaries of the space law world to discuss its exciting past, present and future.
  • View the full release here: https://www.businesswire.com/news/home/20240206427726/en/
    Growing interest in Space Law catalyzed the launch of the Space Beach Law Lab, an unprecedented conference taking place February 27-29, 2024 in Long Beach, California.
  • Space Beach Law Lab is produced by Space Beach, LLC, a consortium of technology and legal community leaders focused on the future.

Allant Group Announces Tim Suther Joining Board of Directors

Retrieved on: 
Tuesday, February 6, 2024
Coalition, Growth, Knowledge, Acxiom, Adtech (company), Marketing, JPMorgan Chase, UnitedHealth Group, Sale, Martech, Committee, Retail

DOWNERS GROVE, Ill., Feb. 6, 2024 /PRNewswire/ -- Allant Group LLC, a data activation solution provider, is pleased to announce Tim Suther has joined the company's Board of Directors. This appointment brings critical expertise in data and technology business development and growth to the board.

Key Points: 
  • DOWNERS GROVE, Ill., Feb. 6, 2024 /PRNewswire/ -- Allant Group LLC, a data activation solution provider, is pleased to announce Tim Suther has joined the company's Board of Directors.
  • Mr. Suther has over three decades maximizing value through data, analytics, and technology transformation.
  • Mr. Suther most recently led Change Healthcare's Data Solutions business, and its subsequent multi-billion-dollar sale and integration into Optum Insight, part of UnitedHealth Group.
  • For more information about Allant Group's data activation, analytics, martech integration, and customer experience management capabilities, please click here .

ZFOX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of ZeroFox to Haveli Investments

Retrieved on: 
Tuesday, February 6, 2024
TipRanks, Wohl, Committee, Stifel, Sale, ZeroFox

MONSEY, N.Y., Feb. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $1.14 per share in cash for which ZeroFox Holdings, Inc. (Nasdaq: ZFOX) (“ZeroFox”) has agreed to be sold to Haveli Investments (“Haveli”).

Key Points: 
  • MONSEY, N.Y., Feb. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $1.14 per share in cash for which ZeroFox Holdings, Inc. (Nasdaq: ZFOX) (“ZeroFox”) has agreed to be sold to Haveli Investments (“Haveli”).
  • The sales price is well below the 52-week high of ZeroFox of $3.49 per share, and well below the price targets of every Wall Street analyst covering ZeroFox (source: TipRanks).
  • If you remain a ZeroFox shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no charge:
    Alternatively, you may contact us by phone at 866-833-6245, or via email at [email protected] .
  • “We are investigating whether the ZeroFox Board acted in the best interests of ZeroFox shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter.

ZeroFox to be Acquired by Haveli

Retrieved on: 
Tuesday, February 6, 2024
Growth, Senior, Committee, Venable LLP, Intelligence, Ropes & Gray, Stifel, ZeroFox, LLP, Organization, Risk management

WASHINGTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- ZeroFox Holdings, Inc. (Nasdaq: ZFOX) (“ZeroFox”), a leading provider of external cybersecurity, today announced that it has entered into a definitive agreement to be acquired by Haveli Investments, a technology-focused private equity firm, in an all-cash transaction with an enterprise value of approximately $350 million.

Key Points: 
  • Under the terms of the merger agreement, ZeroFox stockholders will receive $1.14 per share in cash upon completion of the transaction.
  • With a large and expanding customer base, and consistent growth, ZeroFox is well positioned in an important and expanding category.
  • Piper Sandler is serving as the lead financial advisor to ZeroFox and Stifel served as an additional financial advisor.
  • BTIG and Evercore are serving as financial advisors for Haveli Investments, and BTIG is serving as structuring advisor on debt financing to Haveli Investments.

NYSE to Commence Delisting Proceedings Against Invitae Corporation (NVTA)

Retrieved on: 
Tuesday, February 6, 2024
Professional Services, Finance, New York Stock Exchange, Security (finance), Exchange, Committee

The New York Stock Exchange (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Invitae Corporation (the “Company”) — ticker symbol NVTA — from the NYSE.

Key Points: 
  • The New York Stock Exchange (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Invitae Corporation (the “Company”) — ticker symbol NVTA — from the NYSE.
  • Trading in the Company’s common stock will be suspended immediately.
  • NYSE Regulation has determined that the Company’s common stock is no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Company’s common stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

OneOncology and Coastal Cancer Center Purchase Two Radiation Oncology Centers and Partner with Three South Carolina Radiation Oncologists in Myrtle Beach and Conway

Retrieved on: 
Tuesday, February 6, 2024
Breast, Radiation, GenesisCare, Prostate, Patient, Head, Linearity, Skin, Physician, Neck, Brain, Committee, Community Oncology Alliance, Medical imaging

NASHVILLE, Tenn. and MYRTLE BEACH, S.C., Feb. 6, 2024 /PRNewswire/ -- OneOncology, the fastest-growing national platform for independent oncology practices, and its South Carolina-based partner, Coastal Cancer Center, announced they have purchased two radiation oncology centers located in Myrtle Beach and Conway, South Carolina from GenesisCare. As part of the transaction, three radiation oncologists and 40 employees will join Coastal Cancer Center and continue caring for patients at both locations.  

Key Points: 
  • NASHVILLE, Tenn. and MYRTLE BEACH, S.C., Feb. 6, 2024 /PRNewswire/ -- OneOncology, the fastest-growing national platform for independent oncology practices, and its South Carolina-based partner, Coastal Cancer Center, announced they have purchased two radiation oncology centers located in Myrtle Beach and Conway, South Carolina from GenesisCare.
  • As part of the transaction, three radiation oncologists and 40 employees will join Coastal Cancer Center and continue caring for patients at both locations.
  • OneOncology and Coastal Cancer Center are purchasing two radiation oncology centers located in Myrtle Beach and Conway.
  • The Myrtle Beach radiation oncology center is located at 4708 Oleander Drive and the Conway center is at 8059 Myrtle Trace Drive.